Stock DNTH DIANTHUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Dianthus Therapeutics, Inc.

Equities

DNTH

US2528281080

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
26 USD -3.56% Intraday chart for Dianthus Therapeutics, Inc. +8.51% +150.00%
Jun. 12 Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy MT
Jun. 12 Dianthus Therapeutics Gets FDA Clearance for DNTH103 Phase 2 Trial DJ

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lei Meng Announces Not to Stand for Reelection as Director of Dianthus Therapeutics, Inc
CI
Dianthus Therapeutics, Inc. Announces Executive Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DNTH Stock
  4. News Dianthus Therapeutics, Inc.
  5. Insiders